Beam Therapeutics Inc. (BEAM)

Typically moves ±6.06% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-06 APPROXIMATE

Across 26 earnings reports since Mar 30, 2020, Beam Therapeutics Inc. (BEAM) has a clear post-earnings pattern. It moves ±6.06% on average after reporting and finishes higher 38.5% of the time. Its largest post-earnings gain was +25.89% (Feb 27, 2024) and its largest decline was -19.32% (May 06, 2025). The next earnings report is predicted for 2026-08-06 (approximate).

Earnings reactions

How BEAM moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.06%

Positive %

38.5%

Negative %

61.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☀ PRE	-2.75%	open_in_new
Feb 24, 2026	☀ PRE	+13.98%	open_in_new
Nov 04, 2025	☀ PRE	-6.23%	open_in_new
Aug 05, 2025	☀ PRE	-2.2%	open_in_new
May 06, 2025	☀ PRE	-19.32%	open_in_new
Feb 25, 2025	☀ PRE	-3.09%	open_in_new
Nov 05, 2024	☀ PRE	-1.77%	open_in_new
Aug 06, 2024	☀ PRE	-0.35%	open_in_new
May 07, 2024	☀ PRE	-1.1%	open_in_new
Feb 27, 2024	☀ PRE	+25.89%	open_in_new
Nov 08, 2023	☀ PRE	-8.36%	open_in_new
Aug 08, 2023	☀ PRE	+2.78%	open_in_new
May 10, 2023	☀ PRE	+3.88%	open_in_new
Feb 28, 2023	☀ PRE	+3.21%	open_in_new
Nov 07, 2022	☀ PRE	-11.43%	open_in_new
Aug 09, 2022	☀ PRE	-4.29%	open_in_new
May 09, 2022	☀ PRE	-6.7%	open_in_new
Feb 28, 2022	☀ PRE	+4.82%	open_in_new
Nov 08, 2021	☀ PRE	+10.64%	open_in_new
Aug 10, 2021	☀ PRE	-2.51%	open_in_new
May 11, 2021	☀ PRE	+3.24%	open_in_new
Mar 15, 2021	☀ PRE	-3.66%	open_in_new
Nov 10, 2020	☀ PRE	+2.03%	open_in_new
Aug 12, 2020	☀ PRE	-5.67%	open_in_new
May 12, 2020	☽ POST	+7.27%	open_in_new
Mar 30, 2020	☀ PRE	-0.28%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.06%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 21 →

Funds holding

$435869412

Total value held

Buying

16 added · 4 reduced

Blackrock, Inc.

$202258769 +0.44%

State Street Corp

$135813485 +9.00%

Goldman Sachs Group Inc

$23966855 +92.44%

Northern Trust Corp

$19673572 +2.06%

Morgan Stanley

$15448144 -11.12%

SEC Filing Types

description SCHEDULE 13G/A

15 chevron_right

description SC 13G

13 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260702	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
144	20260630	open_in_new SEC.gov
144	20260629	open_in_new SEC.gov
4	20260629	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
8-K	20260608	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov

Frequently asked about BEAM earnings

When does Beam Therapeutics Inc. report earnings next? expand_more

Beam Therapeutics Inc. (BEAM)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BEAM stock move after earnings? expand_more

Over 26 reports, BEAM has moved an average of ±6.06% the session after earnings, closing higher 38.5% of the time.

What was BEAM's biggest post-earnings move? expand_more

BEAM's largest post-earnings gain on record was +25.89% on Feb 27, 2024, and its largest decline was -19.32% on May 06, 2025.

Where can I find Beam Therapeutics Inc.'s SEC filings? expand_more

All of Beam Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.